Clinical Trial Update: Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating anesthetic options for intravitreal injections. It compares chloroprocaine HCl ophthalmic gel 3% with proparacaine ophthalmic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Diabetic Retinopathy
• Retinal Vein Occlusion

Drugs mentioned

• Chloroprocaine HCl ophthalmic gel 3% (chloroprocaine hydrochloride)
• Lidocaine (Lidocaine)
• Proparacaine ophthalmic solution 0.5% (proparacaine)

Snippet

Sponsor: Harrow Inc | Conditions: Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD) | Phase 4 | Status: ENROLLING_BY_INVITATION